CYTK logo

Cytokinetics, Incorporated (CYTK) Return On Assets

Annual ROA:

-52.97%+4.26%(+7.44%)
December 31, 2024

Summary

  • As of today, CYTK annual return on assets is -52.97%, with the most recent change of +4.26% (+7.44%) on December 31, 2024.
  • During the last 3 years, CYTK annual ROA has fallen by -21.65% (-69.13%).
  • CYTK annual ROA is now -326.66% below its all-time high of 23.37%, reached on December 31, 2009.

Performance

1-Year Change

+7.44%

3-Year Change

-69.13%

5-Year Change

-9.04%

15-Year Change

+3.64%

CYTK ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

36.11%
CYTK annual return on assets is higher than 36.11% of companies in Healthcare sector

Range

All-Time High

23.37%
CYTK annual return on assets is currently -326.66% below its historical high of 23.37%

3-Year Low

-57.23%
CYTK annual return on assets is currently +7.44% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
CYTK previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
CYTK next annual earnings announcement has not yet been scheduled

OtherCYTKprofitability metrics

Annual Revenue

$18.47M
CYTK annual revenue is $18.47 million

Annual Net Income

-$589.53M
CYTK annual net profit is -$589.53 million

Annual EPS

-$5.26
CYTK annual earnings per share is -$5.26

Annual ROE

435.49%
CYTK annual return on equity is 435.49%

Quarterly ROA:

-44.25%+3.57%(+7.47%)
June 30, 2025

Summary

  • As of today, CYTK quarterly return on assets is -44.25%, with the most recent change of +3.57% (+7.47%) on June 30, 2025.
  • Over the past year, CYTK quarterly ROA has increased by +14.05% (+24.10%).
  • CYTK quarterly ROA is now -288.62% below its all-time high of 23.46%, reached on September 30, 2009.

Performance

3-Month Change

+7.47%

1-Year Change

+24.1%

3-Year Change

-58.26%

5-Year Change

+26.59%

CYTK Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

42.96%
CYTK quarterly return on assets is higher than 42.96% of companies in Healthcare sector

Range

All-Time High

23.46%
CYTK quarterly return on assets is currently -288.62% below its historical high of 23.46%

3-Year Low

-65.62%
CYTK quarterly return on assets is currently +32.57% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
CYTK previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 5, 2025
CYTK next earnings announcement is scheduled for Nov 5, 2025

OtherCYTKprofitability metrics

Quarterly Revenue

$66.77M
CYTK quarterly revenue is $66.77 million

Quarterly Net Income

-$134.37M
CYTK quarterly net profit is -$134.37 million

Quarterly EPS

-$1.12
CYTK quarterly earnings per share is -$1.12

Quarterly ROE

309.18%
CYTK quarterly return on equity is 309.18%

ROA Formula

ROA =  Net Income
Total Assets ✕ 100%

Annual ROA

-52.97%
CYTK annual return on assets is -52.97%

Annual Net Income

-$589.53M
CYTK annual net profit is -$589.53 million

Annual Total Assets

$1.40B
CYTK annual total assets is $1.40 billion

CYTK ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+7.4%+24.1%
3Y3 Years-69.1%-58.3%
5Y5 Years-9.0%+26.6%

CYTK ROA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-69.1%+7.4%-37.2%+32.6%
5Y5-Year-71.4%+7.4%-58.3%+32.6%
All-TimeAll-Time-326.7%+27.6%-288.6%+42.6%

CYTK ROA History

DateAnnualQuarterly
Jun 2025
-
-44.25%(+7.5%)
Mar 2025
-
-47.82%(+2.8%)
Dec 2024
-52.97%(+7.4%)
-49.18%(+9.0%)
Sep 2024
-
-54.04%(+7.3%)
Jun 2024
-
-58.30%(+11.2%)
Mar 2024
-
-65.62%(-6.0%)
Dec 2023
-57.23%(-36.6%)
-61.92%(-5.8%)
Sep 2023
-
-58.51%(+1.7%)
Jun 2023
-
-59.53%(-27.4%)
Mar 2023
-
-46.74%(-9.6%)
Dec 2022
-41.91%(-33.8%)
-42.65%(-32.2%)
Sep 2022
-
-32.26%(-15.4%)
Jun 2022
-
-27.96%(+20.4%)
Mar 2022
-
-35.14%(-9.2%)
Dec 2021
-31.32%(-1.3%)
-32.19%(+16.2%)
Sep 2021
-
-38.41%(-17.5%)
Jun 2021
-
-32.70%(-0.5%)
Mar 2021
-
-32.54%(+8.6%)
Dec 2020
-30.91%(+36.4%)
-35.62%(+10.0%)
Sep 2020
-
-39.57%(+34.4%)
Jun 2020
-
-60.28%(-3.5%)
Mar 2020
-
-58.26%(-3.9%)
Dec 2019
-48.58%(-15.6%)
-56.07%(+2.1%)
Sep 2019
-
-57.29%(-13.1%)
Jun 2019
-
-50.65%(-12.2%)
Mar 2019
-
-45.14%(-7.3%)
Dec 2018
-42.01%(+23.6%)
-42.06%(+3.6%)
Sep 2018
-
-43.63%(+0.5%)
Jun 2018
-
-43.87%(-0.0%)
Mar 2018
-
-43.86%(+4.1%)
Dec 2017
-54.97%(-576.8%)
-45.73%(-43.9%)
Sep 2017
-
-31.79%(-358.7%)
Jun 2017
-
-6.93%(-470.6%)
Mar 2017
-
1.87%(-84.9%)
Dec 2016
11.53%(+138.2%)
12.41%(>+9900.0%)
Sep 2016
-
0.06%(+100.2%)
Jun 2016
-
-38.35%(-5.6%)
Mar 2016
-
-36.32%(-13.4%)
Dec 2015
-30.22%(-123.0%)
-32.03%(-80.0%)
Sep 2015
-
-17.79%(-15.7%)
Jun 2015
-
-15.38%(-13.7%)
Mar 2015
-
-13.53%(+6.4%)
Dec 2014
-13.55%
-14.45%(+19.4%)
Sep 2014
-
-17.93%(+27.4%)
Jun 2014
-
-24.70%(+27.5%)
DateAnnualQuarterly
Mar 2014
-
-34.09%(+17.5%)
Dec 2013
-41.95%(+32.3%)
-41.32%(+34.4%)
Sep 2013
-
-63.03%(-6.7%)
Jun 2013
-
-59.06%(-1.0%)
Mar 2013
-
-58.48%(-3.2%)
Dec 2012
-61.95%(+15.4%)
-56.66%(+5.4%)
Sep 2012
-
-59.90%(+5.3%)
Jun 2012
-
-63.22%(+18.0%)
Mar 2012
-
-77.08%(-6.4%)
Dec 2011
-73.20%(-49.0%)
-72.44%(-9.7%)
Sep 2011
-
-66.01%(-5.3%)
Jun 2011
-
-62.67%(-11.2%)
Mar 2011
-
-56.35%(-12.1%)
Dec 2010
-49.14%(-310.3%)
-50.29%(-9.4%)
Sep 2010
-
-45.96%(-21.2%)
Jun 2010
-
-37.92%(-299.4%)
Mar 2010
-
19.02%(-9.9%)
Dec 2009
23.37%(+150.3%)
21.11%(-10.0%)
Sep 2009
-
23.46%(+40.6%)
Jun 2009
-
16.69%(+133.8%)
Mar 2009
-
-49.40%(-5.3%)
Dec 2008
-46.43%(-54.3%)
-46.93%(-8.9%)
Sep 2008
-
-43.10%(-20.8%)
Jun 2008
-
-35.67%(-14.8%)
Mar 2008
-
-31.07%(-8.4%)
Dec 2007
-30.10%(+31.2%)
-28.65%(+10.8%)
Sep 2007
-
-32.13%(+13.4%)
Jun 2007
-
-37.11%(+9.7%)
Mar 2007
-
-41.10%(+15.1%)
Dec 2006
-43.77%(-13.7%)
-48.41%(+4.3%)
Sep 2006
-
-50.61%(-10.3%)
Jun 2006
-
-45.89%(-9.1%)
Mar 2006
-
-42.08%(-7.3%)
Dec 2005
-38.49%(-43.6%)
-39.23%(-7.0%)
Sep 2005
-
-36.68%(-8.8%)
Jun 2005
-
-33.70%(+4.8%)
Mar 2005
-
-35.39%(-12.4%)
Dec 2004
-26.81%(+15.7%)
-31.48%(+4.4%)
Sep 2004
-
-32.93%(+6.4%)
Jun 2004
-
-35.20%(+30.2%)
Mar 2004
-
-50.42%(-1.6%)
Dec 2003
-31.80%(+6.9%)
-49.63%
Dec 2002
-34.15%(-50.6%)
-
Dec 2001
-22.67%(-5.8%)
-
Dec 2000
-21.43%
-

FAQ

  • What is Cytokinetics, Incorporated annual return on assets?
  • What is the all-time high annual ROA for Cytokinetics, Incorporated?
  • What is Cytokinetics, Incorporated annual ROA year-on-year change?
  • What is Cytokinetics, Incorporated quarterly return on assets?
  • What is the all-time high quarterly ROA for Cytokinetics, Incorporated?
  • What is Cytokinetics, Incorporated quarterly ROA year-on-year change?

What is Cytokinetics, Incorporated annual return on assets?

The current annual ROA of CYTK is -52.97%

What is the all-time high annual ROA for Cytokinetics, Incorporated?

Cytokinetics, Incorporated all-time high annual return on assets is 23.37%

What is Cytokinetics, Incorporated annual ROA year-on-year change?

Over the past year, CYTK annual return on assets has changed by +4.26% (+7.44%)

What is Cytokinetics, Incorporated quarterly return on assets?

The current quarterly ROA of CYTK is -44.25%

What is the all-time high quarterly ROA for Cytokinetics, Incorporated?

Cytokinetics, Incorporated all-time high quarterly return on assets is 23.46%

What is Cytokinetics, Incorporated quarterly ROA year-on-year change?

Over the past year, CYTK quarterly return on assets has changed by +14.05% (+24.10%)
On this page